Publications by authors named "Carol Ko"

Claim this Profile
G
Genetic testing impacts the utility of prospective familial screening in hypertrophic cardiomyopathy through identification of a nonfamilial subgroup.
Carol Ko, Patricia Arscott, Maryann Concannon, Sara Saberi, Sharlene M Day

Genet Med· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatic ABCG5/G8 overexpression reduces apoB-lipoproteins and atherosclerosis when cholesterol absorption is inhibited.
Federica Basso, Lita A Freeman, Carol Ko, Charles Joyce, Marcelo J Amar

J Lipid Res· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An apolipoprotein(a) peptide delays chylomicron remnant clearance and increases plasma remnant lipoproteins and atherosclerosis in vivo.
Cecilia M Devlin, Sung-Joon Lee, George Kuriakose, Craig Spencer, Lev Becker, Itamar Grosskopf, Carol Ko, Marlys L Koschinsky

Arterioscler Thromb Vasc Biol· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulation of hepatic apolipoprotein B-lipoprotein assembly and secretion by the availability of fatty acids. I. Differential response to the delivery of fatty acids via albumin or remnant-like emulsion particles.
Yuan-Li Zhang, Antonio Hernandez-Ono, Carol Ko, Koichi Yasunaga, Li-Shin Huang

J Biol Chem· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A fish oil diet produces different degrees of suppression of apoB and triglyceride secretion in human apoB transgenic mouse strains.
Carol Ko, Shawn M O'Rourke, Li-Shin Huang

J Lipid Res· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis